NASDAQ:MOTS - Nasdaq - US62014P5044 - Common Stock - Currency: USD
0.1735
-0.09 (-34.06%)
The current stock price of MOTS is 0.1735 USD. In the past month the price decreased by -72.53%. In the past year, price decreased by -98.67%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Motus GI Holdings Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Fort Lauderdale, Florida and currently employs 43 full-time employees. The company went IPO on 2018-02-14. Motus GI Holdings, Inc. is a medical technology company. The Company, through its subsidiaries in the United States and Israel, is engaged in providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions. The company has developed the Pure-Vu System, a medical device that helps to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable sleeve that fits over standard and slim colonoscopes. The Company’s wholly owned subsidiaries include Motus GI Medical Technologies, Ltd. and Motus GI, LLC.
MOTUS GI HOLDINGS INC
1301 E Broward Blvd Fl 3
FORT LAUDERDALE FLORIDA 33301 US
CEO: Timothy P. Moran
Employees: 43
Company Website: https://www.motusgi.com/
Phone: 17864591831
The current stock price of MOTS is 0.1735 USD. The price decreased by -34.06% in the last trading session.
The exchange symbol of MOTUS GI HOLDINGS INC is MOTS and it is listed on the Nasdaq exchange.
MOTS stock is listed on the Nasdaq exchange.
7 analysts have analysed MOTS and the average price target is 8.47 USD. This implies a price increase of 4779.54% is expected in the next year compared to the current price of 0.1735. Check the MOTUS GI HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MOTUS GI HOLDINGS INC (MOTS) has a market capitalization of 872.70K USD. This makes MOTS a Nano Cap stock.
MOTUS GI HOLDINGS INC (MOTS) currently has 43 employees.
The Revenue of MOTUS GI HOLDINGS INC (MOTS) is expected to grow by 337.5% in the next year. Check the estimates tab for more information on the MOTS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MOTS does not pay a dividend.
MOTUS GI HOLDINGS INC (MOTS) will report earnings on 2024-05-08, after the market close.
MOTUS GI HOLDINGS INC (MOTS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-28.56).
The outstanding short interest for MOTUS GI HOLDINGS INC (MOTS) is 0.12% of its float. Check the ownership tab for more information on the MOTS short interest.
ChartMill assigns a fundamental rating of 2 / 10 to MOTS. MOTS may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months MOTS reported a non-GAAP Earnings per Share(EPS) of -28.56. The EPS increased by 68.99% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -178.25% | ||
ROE | -479.16% | ||
Debt/Equity | 0.46 |
ChartMill assigns a Buy % Consensus number of 83% to MOTS. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 58.34% and a revenue growth 337.5% for MOTS